Elkhorn Partners’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.1K | Buy |
44,500
+6,400
| +17% | +$13.1K | 0.05% | 32 |
|
|
2025
Q4 | $107K | Sell |
38,100
-900
| -2% | -$2.09K | 0.07% | 26 |
|
|
2025
Q3 | $80.3K | Buy |
39,000
+5,000
| +15% | +$13.8K | 0.05% | 28 |
|
|
2025
Q2 | $107K | Buy |
34,000
+1,500
| +5% | +$4.58K | 0.08% | 26 |
|
|
2025
Q1 | $102K | Buy |
32,500
+500
| +2% | +$1.98K | 0.07% | 25 |
|
|
2024
Q4 | $139K | Sell |
32,000
-13,000
| -29% | -$40.6K | 0.09% | 23 |
|
|
2024
Q3 | $120K | Buy |
45,000
+4,000
| +10% | +$9.45K | 0.08% | 27 |
|
|
2024
Q2 | $91K | Buy |
41,000
+2,000
| +5% | +$7.54K | 0.06% | 30 |
|
|
2024
Q1 | $208K | Sell |
39,000
-26,500
| -40% | -$70.4K | 0.15% | 21 |
|
|
2023
Q4 | $97K | Buy |
65,500
+20,500
| +46% | +$24.8K | 0.07% | 30 |
|
|
2023
Q3 | $63K | Sell |
45,000
-2,000
| -4% | -$3.37K | 0.04% | 38 |
|
|
2023
Q2 | $69K | Buy |
47,000
+12,000
| +34% | +$19.4K | 0.04% | 37 |
|
|
2023
Q1 | $58K | Buy |
35,000
+5,592
| +19% | +$9.6K | 0.04% | 33 |
|
|
2022
Q4 | $41K | Buy |
29,408
+4,108
| +16% | +$5.88K | 0.03% | 33 |
|
|
2022
Q3 | $39K | Buy |
25,300
+1,500
| +6% | +$3.61K | 0.03% | 34 |
|
|
2022
Q2 | $52K | Buy |
23,800
+4,800
| +25% | +$8.04K | 0.03% | 34 |
|
|
2022
Q1 | $47K | Buy |
19,000
+1,700
| +10% | +$6.01K | 0.03% | 35 |
|
|
2021
Q4 | $104K | Buy |
17,300
+3,800
| +28% | +$22.6K | 0.06% | 27 |
|
|
2021
Q3 | $90K | Buy |
13,500
+7,500
| +125% | +$47.1K | 0.05% | 30 |
|
|
2021
Q2 | $40K | Buy |
6,000
+4,700
| +362% | +$39.9K | 0.02% | 32 |
|
|
2021
Q1 | $12K | Buy |
1,300
+460
| +55% | +$5.59K | 0.01% | 42 |
|
|
2020
Q4 | $15K | Sell |
840
-160
| -16% | -$2.81K | 0.01% | 31 |
|
|
2020
Q3 | $14K | Sell |
1,000
-6,562
| -87% | -$43.3K | 0.01% | 35 |
|
|
2020
Q2 | $38K | Sell |
7,562
-26,138
| -78% | -$53.5K | 0.03% | 32 |
|
|
2020
Q1 | $34K | Sell |
33,700
-3,300
| -9% | -$4.67K | 0.03% | 32 |
|
|
2019
Q4 | $46K | Hold |
37,000
| – | – | 0.03% | 35 |
|
|
2019
Q3 | $56K | Buy |
37,000
+17,000
| +85% | +$33.1K | 0.03% | 34 |
|
|
2019
Q2 | $50K | Buy |
+20,000
| New | +$64.1K | 0.03% | 33 |
|
|
2019
Q1 | – | Sell |
-14,861
| Closed | -$46K | – | 32 |
|
|
2018
Q4 | $46K | Hold |
14,861
| – | – | 0.03% | 29 |
|
|
2018
Q3 | $73K | Hold |
14,861
| – | – | 0.04% | 28 |
|
|
2018
Q2 | $69K | Buy |
14,861
+10,833
| +269% | +$181K | 0.04% | 32 |
|
|
2018
Q1 | $101K | Hold |
4,028
| – | – | 0.06% | 30 |
|
|
2017
Q4 | $89K | Hold |
4,028
| – | – | 0.06% | 31 |
|
|
2017
Q3 | $212K | Buy |
4,028
+1,500
| +59% | +$93.6K | 0.14% | 33 |
|
|
2017
Q2 | $229K | Hold |
2,528
| – | – | 0.15% | 32 |
|
|
2017
Q1 | $209K | Buy |
2,528
+882
| +54% | +$120K | 0.12% | 33 |
|
|
2016
Q4 | $249K | Buy |
1,646
+945
| +135% | +$221K | 0.15% | 33 |
|
|
2016
Q3 | $227K | Sell |
701
-76
| -10% | -$27.7K | 0.14% | 34 |
|
|
2016
Q2 | $253K | Sell |
777
-70
| -8% | -$24.1K | 0.17% | 34 |
|
|
2016
Q1 | $284K | Buy |
847
+201
| +31% | +$68.4K | 0.17% | 33 |
|
|
2015
Q4 | $251K | Buy |
646
+49
| +8% | +$19.2K | 0.15% | 36 |
|
|
2015
Q3 | $245K | Buy |
+597
| New | +$312K | 0.15% | 39 |
|
Other funds holding CRDF
VCM
LCM
P
ACA
FLPIM